126 related articles for article (PubMed ID: 33545204)
1. Enoxaparin prevents CXCL16/ADAM10-mediated cisplatin renal toxicity: Role of the coagulation system and the transcriptional factor NF-κB.
Aboyoussef AM; Abdel-Sattar AR; Abdel-Bakky MS; Messiha BAS
Life Sci; 2021 Apr; 270():119120. PubMed ID: 33545204
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.
Schramme A; Abdel-Bakky MS; Gutwein P; Obermüller N; Baer PC; Hauser IA; Ludwig A; Gauer S; Schäfer L; Sobkowiak E; Altevogt P; Koziolek M; Kiss E; Gröne HJ; Tikkanen R; Goren I; Radeke H; Pfeilschifter J
Kidney Int; 2008 Aug; 74(3):328-38. PubMed ID: 18480749
[TBL] [Abstract][Full Text] [Related]
4. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
[TBL] [Abstract][Full Text] [Related]
5. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
[TBL] [Abstract][Full Text] [Related]
6. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.
Gutwein P; Abdel-Bakky MS; Schramme A; Doberstein K; Kämpfer-Kolb N; Amann K; Hauser IA; Obermüller N; Bartel C; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
Am J Pathol; 2009 Jun; 174(6):2061-72. PubMed ID: 19435795
[TBL] [Abstract][Full Text] [Related]
7. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.
Hundhausen C; Schulte A; Schulz B; Andrzejewski MG; Schwarz N; von Hundelshausen P; Winter U; Paliga K; Reiss K; Saftig P; Weber C; Ludwig A
J Immunol; 2007 Jun; 178(12):8064-72. PubMed ID: 17548644
[TBL] [Abstract][Full Text] [Related]
8. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
9. Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases.
Schulte A; Schulz B; Andrzejewski MG; Hundhausen C; Mletzko S; Achilles J; Reiss K; Paliga K; Weber C; John SR; Ludwig A
Biochem Biophys Res Commun; 2007 Jun; 358(1):233-40. PubMed ID: 17467666
[TBL] [Abstract][Full Text] [Related]
10. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J
Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211
[TBL] [Abstract][Full Text] [Related]
11. oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.
Chen Y; Wang Z; Li Q; Yu L; Zhu Y; Wang J; Sun S
Mol Med Rep; 2020 Sep; 22(3):1976-1984. PubMed ID: 32705248
[TBL] [Abstract][Full Text] [Related]
12. CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.
Gutwein P; Abdel-Bakky MS; Doberstein K; Schramme A; Beckmann J; Schaefer L; Amann K; Doller A; Kämpfer-Kolb N; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
J Cell Mol Med; 2009 Sep; 13(9B):3809-25. PubMed ID: 19426159
[TBL] [Abstract][Full Text] [Related]
13. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
[No Abstract] [Full Text] [Related]
14. Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Nawaz MI; Ahmad A; De Zutter A; Siddiquei MM; Blanter M; Allegaert E; Gikandi PW; De Hertogh G; Van Damme J; Opdenakker G; Struyf S
Front Immunol; 2020; 11():601639. PubMed ID: 33552057
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
Scholz F; Schulte A; Adamski F; Hundhausen C; Mittag J; Schwarz A; Kruse ML; Proksch E; Ludwig A
J Invest Dermatol; 2007 Jun; 127(6):1444-55. PubMed ID: 17363916
[TBL] [Abstract][Full Text] [Related]
16. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.
Schramme A; Abdel-Bakky MS; Kämpfer-Kolb N; Pfeilschifter J; Gutwein P
Biochem Biophys Res Commun; 2008 May; 370(2):311-6. PubMed ID: 18373975
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S
Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114
[TBL] [Abstract][Full Text] [Related]
18. ADAM10-Interacting Tetraspanins Tspan5 and Tspan17 Regulate VE-Cadherin Expression and Promote T Lymphocyte Transmigration.
Reyat JS; Chimen M; Noy PJ; Szyroka J; Rainger GE; Tomlinson MG
J Immunol; 2017 Jul; 199(2):666-676. PubMed ID: 28600292
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion.
Barlic J; Zhu W; Murphy PM
J Immunol; 2009 Jun; 182(12):7928-36. PubMed ID: 19494317
[TBL] [Abstract][Full Text] [Related]
20. Human P2X7 receptor activation induces the rapid shedding of CXCL16.
Pupovac A; Foster CM; Sluyter R
Biochem Biophys Res Commun; 2013 Mar; 432(4):626-31. PubMed ID: 23428418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]